Skip to main content
Premium Trial:

Request an Annual Quote

Marine Biological Laboratory Dives into Squid Genome Project

NEW YORK, Oct. 24 (GenomeWeb News) - The Marine Biological Laboratory of Woods Hole, Mass., said today that it has launched the Squid Genome Project -- an international effort to sequence and characterize the genome of the calamari squid.


The long-finned squid has a nerve cell fiber, called a giant axon, which is 1,000 times wider than the average human axon. This makes the organism ideal for studying neurological diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's, Huntington's, and Alzheimer's disease, the MBL said.


The effort is co-directed Joe DeGiorgis of MBL and Peter Burbach, of the Rudolf Magnus Institute of Neuroscience at the University Medical Center Utrecht. Support for the project comes from the Laboratory of Neurobiology at the National Institutes of Health and the Netherlands Brain Foundation. Around 41 reserchers worldwide are expected to have some involvement in the project.


So far, DeGiorgis and his colleagues have identified more than 3,000 out of what they predict will total approximately 35,000 genes in the squid genome.


"It's a good beginning, but it's the tip of the iceberg, and completing the project is money dependent," DeGiorgis said in a statement.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.